Literature DB >> 6307064

Differentiation among inhibitory actions of omeprazole, cimetidine, and SCN- on gastric acid secretion.

B Wallmark, B M Jaresten, H Larsson, B Ryberg, A Brändström, E Fellenius.   

Abstract

The action of the substituted benzimidazole omeprazole (H 168/68) was studied in three different in vitro preparations: the isolated guinea pig gastric mucosa, isolated intact and permeable rabbit gastric glands, and hog fundic microsomal membrane vesicles containing H+-K+-ATPase. The effects of omeprazole were compared with those of cimetidine and thiocyanate (SCN-). Under all the conditions studied, cimetidine only counteracted histamine-induced acid secretion, consonant with its H2-receptor antagonism. In contrast, omeprazole and SCN- were found not only to inhibit histamine-induced secretion but also basal acid formation and acid formation induced by dibutyryl cAMP and a high cell medium concentration of K+. Moreover, acid production induced by ATP in permeable gastric glands was antagonized by omeprazole and SCN-, whereas cimetidine was without effect. The interaction pattern of omeprazole and SCN- was differentiated by studies using the weak base antipyrine in the isolated mucosal preparation, where it was found that antipyrine could reverse the inhibition induced by SCN- but not that of omeprazole. Furthermore, omeprazole was found to inhibit the isolated H+-K+-ATPase, whereas cimetidine or SCN- was without effect. In the isolated mucosal preparation omeprazole caused an increase in K+ secretion rates in parallel with the inhibition of acid formation. This was in contrast to what was observed for cimetidine and SCN-, which exhibited no such increased K+ secretion. The results obtained from intact mucosa and isolated glands are in agreement with the ability of omeprazole to inhibit the isolated H+-K+-ATPase and thus provide evidence of a novel mechanism of action for this inhibitor.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6307064     DOI: 10.1152/ajpgi.1983.245.1.G64

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  22 in total

1.  L-365,260 inhibits in vitro acid secretion by interacting with a PKA pathway.

Authors:  C Oiry; J Pannequin; A Cormier; J C Galleyrand; J Martinez
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Dose ranging study of lansoprazole, a new proton pump inhibitor, in patients with high gastric acid secretion.

Authors:  I Berlin; P Molinier; A Duchier; A Cournot; J Durrel; F Dellatolas; J Duchier
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Ultrastructural and cytochemical analysis of Na+, K+, ATPase and H+, K+, ATPase in parietal cells of gastric mucosa in the rabbit.

Authors:  B Pouyet; P Piloquet; N H Vo; G Pradal; G Lefranc
Journal:  Histochemistry       Date:  1992

4.  Oral bioavailability of omeprazole before and after chronic therapy in patients with duodenal ulcer.

Authors:  M S Ching; G W Mihaly; P W Angus; D J Morgan; S Devenish-Meares; N D Yeomans; R A Smallwood
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

Review 5.  Gastric H,K-ATPase as a drug target.

Authors:  Jai Moo Shin; George Sachs
Journal:  Dig Dis Sci       Date:  2006-04-28       Impact factor: 3.199

6.  Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations.

Authors:  Tsukasa Uno; Takenori Niioka; Makoto Hayakari; Norio Yasui-Furukori; Kazunobu Sugawara; Tomonori Tateishi
Journal:  Eur J Clin Pharmacol       Date:  2007-01-04       Impact factor: 2.953

7.  Effects of NC-1300-B, a new benzimidazole derivative, on hog gastric H+, K+-ATPase, gastric acid secretion and HCl.ethanol-induced gastric lesions in rats.

Authors:  S Okabe; Y Akimoto; S Yamasaki; H Nagai
Journal:  Dig Dis Sci       Date:  1988-11       Impact factor: 3.199

8.  Effect of intravenous omeprazole on intragastric pH during intravenous infusion of amino acids.

Authors:  L C Baak; J B Jansen; C B Lamers
Journal:  Dig Dis Sci       Date:  1990-05       Impact factor: 3.199

9.  ATP4A gene regulatory network for fine-tuning of proton pump and ion channels.

Authors:  Vijai Singh; Indra Mani; Dharmendra Kumar Chaudhary
Journal:  Syst Synth Biol       Date:  2013-01-09

Review 10.  Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors:  S P Clissold; D M Campoli-Richards
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.